Introduction
============

Formaldehyde (FA) has traditionally been viewed as a notorious environmental toxin for its carcinogenic effects in mammals. However, it is now evident that FA is also endogenously produced by enzymatic systems mediated by semicarbazide-sensitive amine oxidase (SSAO) [@B1], [@B2], carboxymethyl transferase [@B3], lysine-specific demethylase 1 [@B4], [@B5], *et al*. The presence of these three kinds of syntheses in healthy brain suggests the continuous production of endogenous formaldehyde [@B6]-[@B9]. It has been proposed that endogenous FA participates in spatial memory formation through DNA methylation [@B10]. However, aberrant FA has been implicated in the progression of cognitive impairment [@B11]-[@B14]. To better understand the Janus biological properties of FA, it is essential to have practical methods and tools to detect dynamic changes of FA *in vivo*. Traditional methods for FA analysis have relied on *in vitro* techniques, including gas chromatography [@B15], [@B16], high-performance liquid chromatography [@B17], [@B18], selected ion flow tube mass spectrometry [@B19], [@B20], and radiometry [@B21]. Although these methods have facilitated FA biology study to some extent, they nevertheless suffer from tedious biological sample preparation procedures and the intrinsic inability to detect FA in complex live biological systems.

Fluorescence imaging using small-molecule probes is attracting increasingly more interest. Due to the good biocompatibility of probes, and the straightforward dosing and observation, their scope of applications is extending [@B22]-[@B29]. Recently, there have emerged several elegant fluorescent probes for imaging FA in live cells. However, most of the probes were designed based on an FA-triggered 2-aza-Cope rearrangement and are therefore intrinsically limited by the sluggish detection kinetics and by being irreversible [@B30]-[@B34]. Although the application of the amine-FA condensation reaction has resulted in the development of phenylhydrazine-based probes with improved detection rates [@B35]-[@B37], still improvements could be envisioned including developing faster and reversible probes. Furthermore, previously reported probes are irreversible ones which perform detection by consuming FA permanently and may disturb native FA homeostasis. Moreover, these irreversible probes are incapable of tracking the dynamic homeostasis of endogenous FA. Therefore, fast and reversible probes capable of tracking native FA with high spatiotemporal resolution remains an unmet challenge, which is imperative to understand the pathophysiological roles of FA more accurately.

Herein we present a novel FA fluorescent probe, **PFM**, which was designed by incorporating a stereoelectronic effect to increase the rate of detection and render the probe reversible. Strikingly, **PFM** could detect FA with ultrafast kinetics, and complete response is observed for **PFM** (10 μM) towards FA (200 μM) in less than 1 minute. More impressively, reversibility was demonstrated by first observing the fluorescent response of **PFM** and then scavenging FA led to decreased fluorescence. Re-addition of FA restored the response, and the reversibility tolerates at least three cycles. Moreover, the applicability of **PFM** to image endogenous FA has been confirmed by experiments on neurovascular cells. Further work with *APP/PS1* transgenic mice highlighted the potential of **PFM** for the diagnosis of aberrant FA levels during pathological development.

Experimental section
====================

Materials
---------

Anhydrous toluene was distilled from Na prior to use. Dry CH~2~Cl~2~ was distilled from CaH~2~. Other chemicals and reagents were from commercial supplies and used without further purification. Reactions were monitored by thin layer chromatography using TLC Silica gel 60 F254 supplied by Qingdao Puke Separation Material Corporation, Qingdao, P. R. China, and UV light was used as the visualizing agent. Flash column chromatography was performed using 200-300 mesh silica gel and was supplied by Qingdao Marine Chemical Factory, Qingdao, P. R. China.

Instruments
-----------

^1^H and ^13^C NMR spectra were recorded on a Bruker Fourier transform 500 NMR spectrometer at ambient temperature. CDCl~3~ was used as solvent except otherwise indicated and the spectra were calibrated referencing residual undeuterated solvent as an internal reference (^1^H NMR = 7.26, ^13^C NMR = 77.16). Chemical shifts were given in ppm and coupling constants (*J*) in Hz. Following abbreviations were used to designate multiplicities: s = singlet, d = doublet, m = multiplet. High-resolution mass data were obtained on an Agilent 6224 TOF LC/MS spectrometer using ESI-TOF (electrospray ionization-time of flight). IR spectra were obtained on a Bruker VECTOR FTIR. UV-Vis spectra were taken on a HITACHI U-3010 Spectrophotometer. Fluorescence measurements were performed on an Agilent Cary Eclipse Fluorescence Spectrophotometer with slit widths to be 10 and 10 nm for excitation and emission respectively except otherwise indicated, and the photomultiplier (PMT) detector voltage was set at medium.

Synthesis of PFM
----------------

A mixture of 7-diethylamino-coumarin (0.50 g, 2.3 mmol) and Lawesson reagent (1.9 g, 4.6 mmol) in dry benzene (15 mL) was heated under reflux with an inert atmosphere of nitrogen for 6 h. After being cooled to ambient temperature, the solid precipitate was removed by filtration. The filtrate was concentrated by rotary evaporation, diluted with ethyl acetate (100 mL) and washed subsequently with H~2~O (1×50 mL) and brine (1×50 mL). After being dried over anhydrous Na~2~SO~4~, the solution was concentrated under reduced pressure to give the crude product which was pure enough for further reaction. Part of this crude product (100 mg, ca. 0.43 mmol) was then dissolved in ethanol (5 mL), to which under an inert atmosphere of nitrogen was added hydrazine hydrate (80%, 0.16 mL, 1.6 mmol). The mixture was heated to reflux and kept under reflux for 3 h, then was cooled to ambient temperature. After removal of ethanol by rotary evaporation, the mixture was diluted by the addition of H~2~O (10 mL). The mixture was extracted with CH~2~Cl~2~ (3×20 mL). The combined organic phases were washed with brine (1×20 mL) and dried over anhydrous Na~2~SO~4~. Concentration under reduced pressure gave the crude product which was purified by column chromatography on silica gel eluted with CH~2~Cl~2~ to give **PFM** as a reddish brown solid (64 mg, 66% in two steps). M.p.: 100.5 - 102.5 ^o^C; IR (cm^-1^): 3332, 3177, 2965, 2925, 1605, 1522, 1421, 1354, 1200, 1137, 1078; ^1^H NMR (500 MHz, CDCl~3~): δ 6.98 (d, *J* = 8.8 Hz, 1H), 6.65 (d, *J* = 9.6 Hz, 1H), 6.37 (m, 2H), 5.98 (d, *J* = 9.7 Hz, 1H), 3.37 (q, *J* = 7.1 Hz, 4H), 1.19 (t, *J* = 7.1 Hz, 6H); ^13^C NMR (125 MHz, CDCl~3~): δ 154.60, 148.99, 146.10, 128.51, 127.84, 113.43, 108.88, 106.82, 97.90, 44.64, 12.66; ESI-HRMS (*m/z*): \[M+H\]^+^ calc\'d. for C~13~H~18~N~3~O: 232.1450, found 232.1458.

Fluorometric analysis
---------------------

All the photophysical characterization experiments were carried out at ambient temperature. Deionized water was used to prepare all aqueous solutions. Phosphate buffer saline (PBS, 10 mM) was purged with N~2~ for 5 min before use. **PFM**was dissolved in DMSO to make a 10 mM stock solution. Stock solutions of FA and other bio-relevant species were prepared by dissolving commercial chemicals in deionized water or DMSO. To test the fluorescent response of **PFM** towards FA or other species, aliquots of probe stock solution were diluted with PBS and treated with analytes to make sure both probes and analytes were kept at desired final concentrations. After quick and vigorous shaking, the mixture was allowed standing in the dark for desired time and then the fluorescence spectra were taken with λ~ex~ 451 nm. All fluorometric experiments were performed in triplicate, and data shown were the average.

Cell culture
------------

Human brain microvascular endothelial cell (HBMEC) and human brain vascular pericyte (HBVP) were purchased from Sciencell Research Laboratories (Carlsbad, CA, USA). The HBMECs were maintained in 1640 medium (Invitrogen) and HBVPs were cultured in Dulbecco\'s modified Eagle medium (DMEM, Invitrogen) supplemented with 10% heat-inactivated FBS (Invitrogen), penicillin (100 U/mL) (Invitrogen), and streptomycin (100 U/mL) (Invitrogen). The cultures were maintained at 37 ^o^C in a 95% humidified atmosphere with 5% CO~2~.

Cytotoxicity assay for PFM
--------------------------

HBMECs and HBVPs were seeded in 96-well plates at a density of 5×10^3^ cells/well at 37 ^o^C in a 95% humidified atmosphere with 5% CO~2~ for 24 h. After washing with PBS twice, **PFM** with concentration of 1 μM, 5 μM, 10 μM, 25 μM, 50 μM, and 100 μM were added to the cells, which were allowed an incubation period of 3 h, 6 h, 12 h, 24 h, 48 h. After introducing 10 μL of CCK8 solution for 1 h, the absorption at 450 nm was measured by Microplate Spectrophotometer (MD I3X). Each experiment was repeated three times, and the average values were taken in analyses.

Flow cytometric analysis
------------------------

Samples of HBMECs and HBVPs for flow cytometry were prepared by passaging and seeding in 25T Flask (Corning) before experiments. Cells of 70% confluency were trypsinized, pelleted *via* centrifugation, resuspended in medium. For analysis of exogenous FA in HBMECs and HBVPs, cells were fist stained with **PFM** (10 μM) for 15 min at 37 ^o^C, and then incubated with 0.2 mM, 0.5 mM, 2 mM FA, or 5 mM FA at 37 ^o^C for 15 min. For analysis of endogenous FA in living HBMECs and HBVPs, cells were incubated with 10 μM **PFM** with or without NaHSO~3~ pre-treatment. Excitation was provided by the 488 nm HeNe laser. Each plot represented 10,000 viable cells, non-viable cells were excluded from FACS analysis by appropriate gating. All data analyses were carried out using Cell Quest software (Becton Dickinson).

Brain slices preparation
------------------------

*APP^swe^/PS1* (B6.Cg-Tg (*APP*^swe^, PSEN1dE9) 85Dbo/Mmjax mice (Stock No. 34832, Jackson Laboratory)) and wild-type C57BL/6 mice were housed under a 12 h light/dark schedule and had access to food and water *ad libitum*. All experiments and protocols were approved by the Zhejiang University Animal Experimentation Committee and were in complete compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. *APP/PS1* transgenic mice or C57BL/6 mice were rapidly decapitated, and then the brain was quickly removed and submerged in a 4 ^o^C modified artificial cerebrospinal fluid (ACSF) containing (in mM): 75 sucrose, 87 NaCl, 2.5 KCl, 15 NaH~2~PO~4~, 7 MgCl~2~, 0.5 CaCl~2~, 25 NaHCO~3~ and 25 glucose. The brain was then extracted and glued on the platform of a semiautomatic vibrating blade microtome (VT1000; Leica). The platform was then placed in the slicing chamber containing modified ACSF at 4 ^o^C. Coronal sections of 300 µm containing the hippocampus were collected in a holding chamber filled with ACSF saturated with 95% O~2~ and 5% CO~2~, containing (in mM): 124 NaCl, 3 KCl, 1.25 NaH~2~PO~4~, 1.0 MgSO~4~, 2 CaCl~2~, 26 NaHCO~3~, 10 glucose for a minimum of 30 min at 34ºC, then the temperature was maintained at room temperature prior to use.

Confocal fluorescence imaging
-----------------------------

For confocal fluorescent imaging experiments to detect exogenous FA in living HBMECs and HBVPs, cells were treated with 10 μM **PFM** for 15 min, washed with PBS (pH 7.4), followed without or with the incubation of 200 μM FA for 15 min. For the fluorescence imaging experiments of endogenous FA in living brain cells, HBMECs and HBVPs were incubated without or with 200 μM NaHSO~3~ for 30 min, and then washed with PBS (pH 7.4), followed by 10 μM **PFM** incubation for 15 min. The residual probe was washed three times before imaging. Digital images were captured using the FV10-ASW 3.0 viewer software (Olympus). Cell counts were performed using a 4×, 20×, 40×, or 60× objective in at least five fields of view randomly selected from each coverslip. At least 3 independent experiments were counted. For real-time visualization of endogenous and exogenous FA in HBMECs, cells were incubated with 10 μM **PFM**after being treated with exogenous FA (500 μM), thapsigargin (5 μM), or NaHSO~3~ (200 μM) for 30 min, and fluorescence were obtained with a confocal laser scanning microscope (Olympus, FV1000). For imaging endogenous FA in living brain tissue slides, tissue slides were first incubated without or with 200 μM NaHSO~3~ for 30 min, followed by incubation with 20 μM **PFM** for another 30 min. The fluorescence density was analyzed using Image J software (NIH, Bethesda, MD, USA).

Results and Discussion
======================

Due to its good fluorescent properties and the nature as a privileged structure in drug discovery which might endow the probe with physicochemical properties desirable for *in vivo*application [@B38], the coumarin scaffold was chosen as the prime building block for probe development and **PFM** was devised by introducing a hydrazonate group to C-2 position of 7-(diethylamino) coumarin. We envisioned that due to the hyperconjugation of the lone pair electrons on the oxygen atom to the antibonding C=N (Figure [1](#F1){ref-type="fig"}), the hydrazonate in **PFM** should be of potent nucleophilicity to readily react with FA to form an imine bond which, in turn, may change the fluorescence profile of **PFM** due to the altered degree of electronic polarization in the coumarin electronic system. To test this hypothesis on the stereoelectronic effect, calculations on the electron density of the terminal nitrogen were conducted with 7-(diethylamino)-2-hydrazononaphthalen as a control (Figure [S1](#SM0){ref-type="supplementary-material"}). It turned out that the hydrazone terminal nitrogen of the control compound has less electron density than that of **PFM**, justifying the rationality of the hydrazonate group as a FA-targeting moiety. Furthermore, it is also hypothesized that because of the neighboring electron-withdrawing C=N bond, the newly formed imine bond might be hydrolyzed easily in aqueous solution to fulfill the reversible detection of FA. **PFM** were facilely prepared as detailed above.

With **PFM** in hand, its spectroscopic responses towards FA in aqueous solution were first characterized. As shown in Figure [2](#F2){ref-type="fig"}A, **PFM** in phosphate buffer solution (PBS, 10 mM, pH 7.4) showed its maximum absorption at 364 nm (ε 18 710 M^-1^ cm^-1^, Ф 0.003), whereas the treatment of FA caused a dose-dependent bathochromic-shift of its absorption and reached the plateau at 393 nm (ε 19 325 M^-1^ cm^-1^, Ф 0.029). In contrast to the highly emissive 7-(diethylamino) coumarin, **PFM**was almost non-fluorescent in PBS, presumably due to the substitution of the less electron-withdrawing hydrazonate group which decreased the electronic push-pull effect. However, FA treatment induced a dose-dependent increase of the fluorescence centered at 500 nm (Figure [2](#F2){ref-type="fig"}B), suggesting the conversion of the hydrazonate group to *Nˈ*-methylenehydrazonate which made the probe a more electron-donor-acceptor system. Coinciding with the spectroscopic responses, NMR titration experiments provided direct evidence in support of the formation of *Nˈ*-methylenehydrazonate group (Figure [S2](#SM0){ref-type="supplementary-material"}). These results taken together, implied an "intramolecular charge transfer (ICT)" mechanism for **PFM** fluorescence quenching [@B39]. Furthermore, plot of the fluorescent intensity (F) versus the concentrations of FA gave an exponential dependence (Figure [S3](#SM0){ref-type="supplementary-material"}), with concentrations of FA higher than 500 μM bringing the response to its maximum (F~max~). Interestingly, the Napierian logarithm of F~max~ minus F correlated linearly with the corresponding FA concentrations ranging from 0 to 200 μM (Figure [S4](#SM0){ref-type="supplementary-material"}), which happens to fall into the reported biologically relevant range of FA [@B40], implying the great potential of the probe to quantify endogenous FA. The detection limit of **PFM** was found to be as low as 0.4 μM (Figure [S5](#SM0){ref-type="supplementary-material"}). To further confirm the rapid detection kinetics of **PFM**, we recorded its intensity at emission maximum (λ~em~ 500 nm) as time lapsed upon the treatment of various concentrations of FA, and it turned out that the reaction ran fast enough to complete in 1 min, even with FA concentration as low as 10 μM (Figure [2](#F2){ref-type="fig"}C). This ultrafast detection kinetics and the low detection limit highlight **PFM** as the most sensitive fluorescent probe for FA ever. Notably, the fluorogenic response of **PFM** was found to be selective for FA over other potentially competing biological carbonyl species such as glucose, glyoxal, methylglyoxal, acetaldehyde, *etc* (Figure [2](#F2){ref-type="fig"}D, Figure [S6](#SM0){ref-type="supplementary-material"}). In fact, treating **PFM** (10 μM) with FA (300 μM) caused a 68-fold fluorescence enhancement. While among the other analytes, only methylglyoxal, glyoxal and HClO caused intensity enhancement of 3.8, 3.5, and 2.2-fold respectively (Figure [S7](#SM0){ref-type="supplementary-material"}), suggesting the high specificity of **PFM** towards FA. It is noteworthy that**PFM** retains its sensitivity for FA even in the presence of the above-mentioned analytes (Figure [2](#F2){ref-type="fig"}D, Figure [S8](#SM0){ref-type="supplementary-material"}), indicating the potential of **PFM** to detect FA in more complicated biological contexts. We also studied the influence of surrounding pH changes to the detection reaction, and it turned out that although a gradual fluorescence increase occurred to **PFM** alone as pH values decreased from pH 7.4 to pH 4.5 as a result of protonation of the amino group (Figure [S9](#SM0){ref-type="supplementary-material"}), this effect causes little detriment to the detection sensitivity of **PFM** towards FA in the pH range of 7.4-6.0 (Figure [S10](#SM0){ref-type="supplementary-material"}). Photostability of both **PFM** and the reaction product was evaluated by keeping the samples under continuous excitation. The results showed that **PFM** retained its sensitivity for FA even after a long irradiation time, and that the fluorescence intensity of **PFM**-FA remained unchanged after continuous excitation as long as 50 min (Figure [S11](#SM0){ref-type="supplementary-material"}).

Finally, to test if **PFM** could detect FA in a reversible way, NaHSO~3~ (200 μM) was added as a FA scavenger to the probe (10 μM)-FA (200 μM) solution. The emission intensity was decreased to almost the original level of the probe blank solution. However, re-addition of another portion of FA (200 μM) restored the fluorescent intensity to just about the level before NaHSO~3~ was added (Figure [S12](#SM0){ref-type="supplementary-material"}). This cycle could be repeated for at least twice, indicting the reversibility of the detection. Furthermore, based on the dose-response plot of **PFM** to FA (Figure [S13](#SM0){ref-type="supplementary-material"}), we were able to calculate the dissociation constant of **PFM** toward FA (*K*~d,\ FA~) to be around 100 μM employing a literature method [@B41].

Having established **PFM** as a robust probe to detect FA in aqueous solution, we next moved to investigate its applicability to image FA in live cells, and the cytotoxicity of **PFM** was first assayed for this purpose. CCK8 assay carried out in Human brain microvessel endothelial cells (HBMECs) and human brain vascular pericytes (HBVPs) showed that **PFM** remained weakly cytotoxic to neurovascular cells at concentrations up to 100 μM with prolonged treatment time of 48 h (Figure [S14](#SM0){ref-type="supplementary-material"}). Confocal microscopy and flow cytometry were then used to investigate the capability of **PFM** for real-time bioimaging of exogenous FA in live neurovascular cells. HMBEC or HBVP cells were treated with **PFM** (10 μM) for 15 min followed by washing to remove excess probe. The fluorescence intensities of **PFM** were monitored following various concentrations of FA treatment (0, 0.2, 0.5, 2.5 and 5 mM), and a significant increase of intracellular probe fluorescence was observed which correlated with FA concentrations (Figure [3](#F3){ref-type="fig"} and S15). We also quantified the fluorescence intensities by flow cytometry analysis, and found that significant intracellular **PFM** fluorescence increased in a dose-dependent manner following FA treatment (Figure [S16](#SM0){ref-type="supplementary-material"}C, S17C, S18), demonstrating the feasibility of **PFM** as a bioimaging probe for detecting FA in neurovascular cells.

As endogenous FA has been reported to be expressed in neurovascular cells [@B11], [@B14], we were therefore keen to know if **PFM** could be sensitive enough to image native FA in intact cells. As shown in Figure [4](#F4){ref-type="fig"}A and Figure [S19](#SM0){ref-type="supplementary-material"}B, probe-loaded HBMECs and HBVPs exhibited significant intracellular fluorescence even without exogenous FA. However, pre-incubation of the cells with NaHSO~3~(a FA scavenger) blunted intracellular fluorescence (Figure [4](#F4){ref-type="fig"}B and Figure [S19](#SM0){ref-type="supplementary-material"}C) [@B35], indicating the presence of endogenous FA. We thus conclude that **PFM** is a cell permeable, non-toxic small molecule probe capable of imaging native FA in live neurovascular cells, which should be the prerequisite for dynamically tracking FA fluxes in live cells.

We next addressed whether **PFM** retained its ultrafast response towards FA in neurovascular cells. As shown in Figure [S20](#SM0){ref-type="supplementary-material"} and video [S1](#SM0){ref-type="supplementary-material"}, significant intracellular fluorescence could be observed even 1 min after **PFM** incubation. Fluorescence intensity of **PFM** peaked after 20 min of incubation. Moreover, further increase of **PFM** fluorescence were observed when cells were exposed to exogenous FA (video [S2](#SM0){ref-type="supplementary-material"} and Figure [S21](#SM0){ref-type="supplementary-material"}), whereas NaHSO~3~ (200 μM) pre-treatment partially reduced the **PFM** response to exogenous FA (video [S3](#SM0){ref-type="supplementary-material"} and Figure [S22](#SM0){ref-type="supplementary-material"}). These results thus show time-dependent and reversible character of probe **PFM**. Since excess formaldehyde has been reported to cause hyper-modification and misfolding of proteins, leading to endoplasmic reticulum stress [@B42], we therefore employed an ER stress model to stimulate the burst of native FA in live cells. As shown in Figure [S23](#SM0){ref-type="supplementary-material"}, ER stress caused by thapsigargin (TG) or tunicamycin (TM) treatment resulted in significantly increased intracellular **PFM** fluorescence, while time lapse live cell imaging of HBMECs revealed a 5-fold increase in the fluorescence intensity of **PFM** probe after being subjected to thapsigargin (TG, 5 μM) stimulation within one-hour time frame (Figure [5](#F5){ref-type="fig"}, video [S4](#SM0){ref-type="supplementary-material"}). Our present results implicated that **PFM** is suitable to monitor the dynamic changes of endogenous FA in neurovascular cells, which could be useful to address the mechanisms involved in the pathological process of neurovascular disorders

Finally, the capability of **PFM** to image endogenous FA in mice brain tissues was tested. To this end, **PFM** was first examined for its sensitivity and specificity to detect exogenous FA in brain tissues from 3-month old mice, with and without NaHSO~3~ pretreatment. In good agreement with the above cell-based results, our data demonstrated significantly higher **PFM** fluorescence in cerebral cortex (Figure [S24](#SM0){ref-type="supplementary-material"}) pretreated with FA compared with those pretreated with NaHSO~3~. Since excessive elevation of endogenous FA has been implicated in the pathological progression of neurodegenerative pathology [@B11]-[@B14], we therefore assessed whether **PFM** could be used to monitor aberrant FA levels in brain tissues of aging or *APP/PS1* transgenic mice. This translation to *ex vivo* pathological model imaging showed that significant**PFM** fluorescence elevation was observed in hippocampus (Figure [6](#F6){ref-type="fig"}) and brain cortex (Figure [S25](#SM0){ref-type="supplementary-material"} and S26) of 14-month-old C57BL/6 mice and *APP/PS1* transgenic mice compared with 3-month-old C57BL/6 mice, indicating the correlation between FA levels and neurodegenerative process.

Conclusions
===========

We have developed a coumarine-hydrazonate based fluorogenic probe for the ultrafast detection of FA in intact biological samples. Apart from its desired biocompatibility, this probe has the advantage of detecting FA with fast kinetics and in a reversible manner. In combination with a pharmacological approach, we have confirmed that **PFM** can detect endogenous FA in neurovascular cells swiftly and specifically with good spatiotemporal sensitivity. Moreover, **PFM**-assisted fluorescence detection of FA in pathological samples obtained from *APP/PS1* transgenic mice further highlights the diagnostic potentials of **PFM** for neurodegenerative diseases. **PFM** may be used in future to unlock the molecular basis behind the correlation between FA levels and progression of neurodegenerative diseases.
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![Structure and design philosophy of **PFM**.](thnov07p2305g001){#F1}

![Photophysical responses of **PFM** to FA. (A) **PFM**(20 μM) was treated with various amounts of FA for 5 min, and then the UV-vis spectra were recorded. (B) Fluorescent spectra of **PFM**(10 μM) after the treatment of various concentrations of FA for 5 min. (C) Reaction time course of **PFM** (10 μM) with FA (10, 100, 200, 400 μM). (D) Fluorescent responses of **PFM** (10 μM) toward various analytes (300 μM) after a reaction time of 30 min without (black) or with (red) the presence of FA (300 μM). The analytes tested were **PFM** blank (1), acetaldehyde (2), malonaldehyde (3), ascorbic acid (4), glucose (5), glucosone (6), oxalic acid (7), pyruvate (8), methylglyoxal (9), glyoxal (10), *p*-methoxybenzaldehyde (11), trichloroacetaldehyde (12), *p*-nitrobenzaldehyde (13), acetone (14), HClO (15), H~2~O~2~ (16), GSH (17). For C and D, F represents the fluorescent intensity of **PFM** at 500 nm after the treatment of FA for various time or after the treatment of various analytes, and F~0~ represents the intensity of blank **PFM** solution at 500 nm. All data were collected in PBS (pH 7.4, 10 mM) at ambient temperature with λ~ex~ 451 nm.](thnov07p2305g002){#F2}

![Confocal imaging of **PFM** for detecting exogenous FA in living HBMECs (A, B, C, D, E). Cells are treated with 10 μM **PFM** for 15 min at 37 ^o^C, then washed with PBS (pH 7.4), and followed by FA incubation for 15 min. control (A); 0.2 mM FA (B); 0.5 mM FA (C); 2.5 mM FA (D); 5 mM FA (E). (F) Quantification of image data in (A-E). Data are expressed as mean±S.E.M. A minimum of 3 images for each condition were quantified and averaged. \*\*\**P*\<0.01 *versus* control. The **PFM** fluorescence was monitored at 515-545 nm (*λ*~ex~=488 nm). Scale bar=20 μm.](thnov07p2305g003){#F3}

![Imaging endogenous FA in live HBMECs. (A) HBMECs treated with **PFM** (10 μM). (B) HBMECs were pre-treated with NaHSO~3~(200 μM) for 30 min, then washed with PBS (pH 7.4) and followed by **PFM**(10 μM) incubation for 15 min at 37^o^C. (C) HBMECs treated with NaHSO~3~ (200 μM). Nuclei were stained with Hoechst 33342. (D) Quantification of image data. Data are expressed as mean±S.E.M. A minimum of 3 images for each condition were quantified and averaged. \*\**P*\<0.01 *versus* **PFM** alone. The **PFM** fluorescence was monitored at 515-545 nm (*λ*~ex~=488 nm).](thnov07p2305g004){#F4}

![Real-time visualization of endogenous FA in living HBMECs upon ER stress. The time-series images are individual frames from a continuous time-lapse movie and show dynamic fluorescence elevation with **PFM (**10 μM**)** treatment (A, B, C) and thapsigargin (TG, 5 μM) stimulation (D, E, F, G, H). (I) Mean values of fluorescence intensity from time-lapse movie (video [S4](#SM0){ref-type="supplementary-material"}) were measured to quantify the endogenous FA production upon TG treatment. The arrowheads indicate the same position of the target cell. The **PFM** fluorescence was monitored at 515-545 nm (*λ*~ex~=488 nm).](thnov07p2305g005){#F5}

![Application of **PFM** for monitoring endogenous FA in living brain slices of C57BL/6 and *APP/PS1* transgenic mice. Fluorescence images of hippocampus of C57BL/6 and *APP/PS1* transgenic mice incubated with **PFM** (20 μM) for 30 min, (A, D, G) 3 month old C57BL/6 mice, (B, E, H) 14 month old C57BL/6 mice, (C, F, I) *APP/PS1* transgenic mice. The arrow indicated the cells with high fluorescence. Scale bar=100 μm. Fluorescence images of hippocapus of C57BL/6 (J, L) and *APP/PS1* transgenic mice (K, M), Scale bar=20 μm. (N) Quantification of image data represented by D1 and D2. Data are expressed as mean±S.E.M., a minimum of 3 images for each condition were quantified and averaged. \*\*\**P*\<0.001 *versus* C57BL/6 mice. The **PFM** fluorescence was monitored at 515-545 nm (*λ*~ex~=488 nm). Nuclei were stained with Hoechst 33342 (blue).](thnov07p2305g006){#F6}
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